Transcriptional mediators of treatment resistance in lethal prostate cancer.

If the proportion of nominally significant results ( P < 0.05, same direction of effect as the overall median outcome for the given signature) when the biopsy was excluded was <80% of the proportion of nominally significant results when the biopsy was included, we considered any overall finding of differential gene set expression as nonrobust.

also in 7,732 other papers